Medications

British drugmaker cutting hundreds of US jobs

Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year under the pharmaceutical industry's latest restructuring.

Surgery

Study examines impact of minimally invasive surgery

(HealthDay)—For specific types of surgery, minimally invasive procedures correlate with significantly lower health plan spending and fewer days of absence from work, compared with standard surgery, according to a study ...

Medications

Novartis reshapes business with GSK, Lilly deals (Update)

Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more ...

Medications

Pharma data play larger role in anti-doping effort

Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this year's Winter Olympics: They're providing information on drugs that once would have been considered proprietary trade secrets.

Medications

Save the Children teams up with pharma giant GSK in Africa

International development charity Save the Children is linking up with British pharmaceutical giant GlaxoSmithKline in what both sides say is a unique collaboration to save children's lives in Africa.

Other

Human Genome agrees to GlaxoSmithKline takeover (Update)

(AP) — U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK's drug portfolio in crucial areas: biologic drugs and treatments ...

page 9 from 18